U.S. Congestive Heart Failure Medications Markets

 

USD 3,950

* Required Fields

USD 3,950

PAY BY INVOICE

Be the first to review this product

This report forecasts the U.S. Congestive Heart Failure(CHF) Medications Market for the period 1997 to 2007, with 2000 as the base year. There are two segments in this market, the ACE inhibitors and the Beta Blockers.This report discusses the challenges,drivers and restraints and their impact on future revenues and growth rates. The competitive structure of the total market,as well as each individual segment is analyzed. Demand analysis, market share analysis and technology trends are discussed. Product analysis in each segment is done and Emerging therapeutics for CHF are also discussed and their likely impact on existing therapies analyzed. Finally, conclusions are inferred and strategic recommendations made.

Table of Contents

U.S. Congestive Heart Failure Medications Markets, Executive SummaryMarket OverviewIntroductionCompetitive AnalysisTechnologiesMajor Research FindingsOpportunities and ForecastsMarket Segment AnalysisU.S. Congestive Heart Failure Medications Markets, Total MarketOverview and DefinitionsIntroductionChallengesMarket Engineering AnalysisMarket DriversMarket RestraintsForecasts and TrendsRevenue ForecastsDemand AnalysisMarket and Technology TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct AnalysisStrategic RecommendationsStrategic RecommendationsMarket Engineering AwardsMarket Engineering Leadership Award: GlaxoSmithKline Market Engineering Leadership Award, Ace Inhibitor: Merck & Co.Entrepreneurial Company Award: Scios IncorporatedProduct Innovation: Bristol-Myers Squibb CorporationMarketing Strategy Awards: King PharmaceuticalsU.S. Congestive Heart Failure Medications Markets, ACE Inhibitor MarketOverview and DefinitionsIntroductionChallengesMarket Engineering AnalysisMarket DriversMarket RestraintsForecasts and TrendsRevenue ForecastsDemand AnalysisMarket and Technology TrendsPricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct AnalysisOff Label MedicationsStrategic RecommendationsEstablish Relationships StrategyAwareness and Education StrategyReform of Healthcare Payment System StrategyCost Saving StrategyU.S. Congestive Heart Failure Medications Markets, Beta Blockers MarketOverview and DefinitionsIntroductionChallengesMarket Engineering AnalysisMarket DriversMarket RestraintsForecasts and TrendsRevenue ForecastsDemand AnalysisMarket and Technology TrendsPricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct AnalysisOff Label MedicationsRecommendations and EvaluationStrategic RecommendationsU.S. Congestive Heart Failure Medications Markets, Emerging TherapeuticsOverview and DefinitionsIntroductionChallengesOpportunitiesTrendsMarket Entrance ForecastDemand AnalysisMarket and Technology TrendsCompetitive AnalysisCompetitive StructureProduct Analysis




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 15-Nov-17

Region : North America

Release Date : 15-Nov-17

Region : North America

Release Date : 13-Nov-17

Region : North America

Release Date : 13-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.